Do DNA-methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 1, 2011, Pages 149-158

  Minardi, Daniele ^a   Lucarini, G ^a   Filosa, A ^a   Zizzi, A ^a   Milanese, G ^a   Polito Jr , M ^a   Polito, M ^a   Di Primio, R ^a   Montironi, R ^a   Muzzonigro, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Clear cell renal carcinoma; DNA methylation; Fuhrman grade; Histone acetylation; Immunohistochemistry

Indexed keywords

5 METHYLCYTOSINE; ACETYLHISTONE; HISTONE; UNCLASSIFIED DRUG; LYSINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CANCER TISSUE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DIAGNOSTIC TEST; DNA METHYLATION; FEMALE; FOLLOW UP; GLOBAL METHYLATION; HISTONE ACETYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; ACETYLATION; CANCER STAGING; GENETICS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY;

5-METHYLCYTOSINE; ACETYLATION; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DNA METHYLATION; FEMALE; FOLLOW-UP STUDIES; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY;

EID: 79957798455     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400117     Document Type: Article

References (33)

1. Jemal A, Tiwari RC, Murray T, Singh GK, Cardinez C, Ghafoor A, Thun M. Cancer statistics 2004. CA Cancer J Clin 2004; 54:8-29.
2. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003; 30:843-52. (Pubitemid 37485197)
3. Ljungberg B. Prognostic markers in renal cell carcinoma. Curr Opin Urol 2007; 17:303-8. (Pubitemid 47344615)
4. Minardi D, Lucarini G, Mazzucchelli R, Milanese G, Natali D, Galosi AB, Montironi R, Biagini G, Muzzonigro G. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell renal carcinoma in partial nephrectomy specimens. J Urol 2005; 174:1208-12. (Pubitemid 41318683)
5. Minardi D, Lucarini G, Filosa A, Milanese G, Zizzi A, Di Primio R, Montironi R, Muzzonigro G. Prognostic role of global DNA-methylation and histone acetylation in pT1a clear cell renal carcinoma in partial nephrectomy specimens. J Cell Mol Med 2009; 13:2115-21.
6. Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Bergh A, Ljungberg B. Hypoxia-inducible factor 1 alpha expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol 2006; 50:1272-7. (Pubitemid 44692925)
7. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005; 173:1853-62. (Pubitemid 40675199)
8. Herranz M, Esteller M. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Methods Mol Biol 2007; 36:25-62. (Pubitemid 350183201)
9. Cassiman JJ. Epigenetics: a major cause of variations on the same theme. J Cell Mol Med 2006; 10:552-53.
10. Mohamed MA, Greif PA, Diamond J, Sharaf O, Maxwell P, Montironi R, Young RA, Hamilton PW. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int 2007; 99:908-15. (Pubitemid 46439577)
11. Piyathilake CJ, Bell WC, Jones J, Henao OL, Heimburger DC, Niveleau A, Grizzle WE. Patterns of global DNA and histone methylation appear to be similar in normal, dysplastic and neoplastic oral epithelium of humans. Dis Markers 2005; 21:147-51. (Pubitemid 41566733)
12. Marino-Ramirez L, Kann MG, Shoemaker BA, Landsman D. Histone structure and nucleosome stability. Expert Rev Proteomics 2005; 2:719-29. (Pubitemid 41492393)
13. Orr JA, Hamilton PW. Histone acetylation and chromatin pattern in cancer. A review. Anal Quant Cytol Histol 2007; 29:17-31. (Pubitemid 46333518)
14. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6:655-63. (Pubitemid 13234762)
15. th ed. New York: Wiley-Liss, 2002, p. 193.
16. Piyathilake CJ, Henao O, Frost AR, Macaluso M, Bell WC, Johanning GL, Heimburger DC, Niveleau A, Grizzle WE. Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States). Cancer Causes Control 2003; 14:37-42. (Pubitemid 36403267)
17. Lu TY, Kao CF, Ling CT, Huang DY, Chiu CY, Huang YS, Wu HC. DNA methylation and histone modification regulate silencing of OPG during tumor progression. J Cell Bioch 2009; 108:315-25.
18. Barbisan F, Mazzucchelli R, Santinelli A, Stramazzotti D, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R. Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential. Int J Immunopath Pharmacol 2008; 21:615-23.
19. Arai E, Ushijima S, Fujimoto H, et al. Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome. Carcinogenesis 2009; 30:214-21.
20. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447:433-40. (Pubitemid 46816750)
21. Piyathilake CJ, Johanning GL, Frost AR, Whiteside MA, Manne U, Grizzle WE, Heimburger DC, Niveleau A. Immunohistochemical evaluation of global DNA methylation: comparison with in vitro radiolabeled methyl incorporation assay. Biotech Histochem 2000; 75:251-58.
22. Herranz M, Esteller M. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Methods Mol Biol 2007; 361:25-62. (Pubitemid 350183201)
23. Fahrner JA, Eguchi S, Herman JG, Baylin SB. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 2002; 62:7213-18. (Pubitemid 36025241)
24. Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Köllermann J, Miller K, Schrader M. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications. Clin Cancer Res 2006; 12:5040-46. (Pubitemid 44453329)
25. Yamada D, Kikuchi S, Williams YN, et al. Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma. Int J Cancer 2006; 118:916-23. (Pubitemid 43157666)
26. Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, Brooks JD. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med 2006; 3:e13.
27. Furge KA, Chen J, Koeman J, Swiatek P, Dykema K, Lucin K, Kahnoski R, Yang XJ, Teh BT. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res 2007; 67:3171-76. (Pubitemid 46724854)
28. Mohamed MA, Greif PA, Diamond J, Sharaf O, Maxwell P, Montironi R, Young RA, Hamilton PW. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int 2007; 99:908-15. (Pubitemid 46439577)
29. Dalgin GS, Drever M, Williams T, King T, DeLisi C, Liou LS. Identification of novel epigenetic markers for clear cell renal cell carcinoma. J Urol 2008; 180:1126-30.
30. Kanao K, Milami S, Mizumo R, Shinojima T, Murai M, Oya M. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors. J Urol 2008; 180:1131-36.
31. Ellinger J, Kahl P, Mertens C, Rogenhofer S, Hauser S, Hartmann W, Bastian PJ, Buttner R, Muller SC, Von Ruecker A. Prognostic relevance of global histone H3 Lysine 4 (H3K4) methylation in renal cell carcinoma. Int J Cancer 2010; 127:2360-6.
32. Mosashvilli D, Kahl P, Mertens C, et al. Global histone acetylation levels: Prognostic relevance in patients with renal cell carcinoma. Cancer Sci 2010; 101:2664-69.
33. Seligson DB, Horvarth S, McBrian MA, et al. Global levels of histone modifications predict prognosis in different cancers. Am J Pathol 2009; 174:1619-28.